Overall, these findings indicate that specific patient and disease characteristics, such as sex, age, DR severity, VH, need for anti-VEGF treatment, and DME, can predict the extent of retinal ischemia and neovascularization, potentially enabling personalized surveillance and timely intervention in diabetic retinopathy. The gene discussed is VEGFA; the disease is diabetic retinopathy.